|Day Low/High||2.96 / 3.00|
|52 Wk Low/High||3.68 / 20.43|
Here's a technical look at how to trade several under-$10 stocks triggering breakout trades.
Levi & Korsinsky announces it has commenced an investigation of Nivalis Therapeutics, Inc.
Company to Host Conference Call Today, November 28, at 5:00 p.m. EST
Completion of Enrollment in Phase 2 Study of Cavosonstat for Treatment of Cystic Fibrosis Achieved During the Quarter
Here's a technical look at how to trade several under-$10 stocks that were making big moves to the upside recently.
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Company on track to report results from the study in fourth quarter this year
Industry-leading patient reimbursement solution reaches milestone of 3 million transactions, totaling more than $200 million in patient reimbursements worldwide
N91115 is Currently in a Phase 2 Clinical Trial for Cystic Fibrosis, and Recently Received Orphan Drug Designation